{"id":11655,"date":"2018-06-13T00:00:00","date_gmt":"2018-06-12T17:00:00","guid":{"rendered":"https:\/\/dcl.com.vn\/fit-hoan-thanh-mua-them-2-tri-u-c-phi-u-du-c-c-u-long\/"},"modified":"2018-06-13T00:00:00","modified_gmt":"2018-06-12T17:00:00","slug":"fit-hoan-thanh-mua-them-2-tri-u-c-phi-u-du-c-c-u-long","status":"publish","type":"post","link":"https:\/\/dcl.com.vn\/en\/fit-acquiring-2-million-shares-of-cuu-long-pharmaceutical\/","title":{"rendered":"FIT acquiring 2 million shares of Cuu Long Pharmaceutical"},"content":{"rendered":"
\n
\n
\n
\n

According to the announcement of the F.I.T Group (FIT), the company has completed acquiring of 2 additional million shares of Cuu Long Pharmaceutical JSC.<\/strong><\/em><\/p>\n

With 2 million additional shares, F.I.T currently holds 74.61% of DCL\u2019s shares, equivalent to 42,402,616 stakes. Transaction time were from 01\/06\/2013 to 08\/06\/2018.<\/span>u\u1ea3 kinh doanh c\u1ee7a DCL r\u1ea5t kh\u1ea3 quan, khi li\u00ean t\u1ee5c c\u00f3 s\u1ef1 t\u0103ng tr\u01b0\u1edfng m\u1ea1nh m\u1ebd v\u1ec1 l\u1ee3i nhu\u1eadn theo t\u1eebng n\u0103m. Trong n\u0103m 2018, k\u1ebf ho\u1ea1ch kinh doanh c\u1ee7a D\u01b0\u1ee3c C\u1eedu Long \u0111\u01b0\u1ee3c \u0111\u1eb7t ra v\u1edbi doanh thu thu\u1ea7n l\u00e0 963 t\u1ef7 \u0111\u1ed3ng t\u0103ng 26% ; l\u1ee3i nhu\u1eadn sau thu\u1ebf l\u00e0 86 t\u1ef7 \u0111\u1ed3ng t\u0103ng 15% so v\u1edbi n\u0103m 2017. V\u1edbi nh\u1eefng ho\u1ea1ch \u0111\u1ecbnh, m\u1ee5c ti\u00eau c\u1ee5 th\u1ec3, n\u0103m 2018, DCL s\u1ebd t\u1eadp trung \u0111\u1ea7u t\u01b0 m\u1ea1nh m\u1ebd h\u01a1n n\u1eefa cho ho\u1ea1t \u0111\u1ed9ng s\u1ea3n xu\u1ea5t kinh doanh v\u1edbi n\u1ec1n t\u1ea3ng l\u00e0 t\u1ed1i \u01b0u n\u0103ng l\u1ef1c s\u1ea3n xu\u1ea5t, t\u0103ng s\u1ea3n ph\u1ea9m th\u1eed t\u01b0\u01a1ng \u0111\u01b0\u01a1ng sinh h\u1ecdc, nghi\u00ean c\u1ee9u s\u1ea3n ph\u1ea9m m\u1edbi ph\u00f9 h\u1ee3p xu th\u1ebf th\u1ecb tr\u01b0\u1eddng, ho\u00e0n thi\u1ec7n h\u1ec7 th\u1ed1ng b\u00e1n h\u00e0ng, chu\u1ea9n h\u00f3a n\u0103ng l\u1ef1c b\u1ed9 m\u00e1y nh\u00e2n s\u1ef1, chuy\u00ean nghi\u1ec7p h\u00f3a c\u00f4ng t\u00e1c qu\u1ea3n tr\u1ecb \u0111i\u1ec1u h\u00e0nh, \u0111\u1ea3m b\u1ea3o t\u00ecnh h\u00ecnh t\u00e0i ch\u00ednh v\u1eefng m\u1ea1nh.\u00a0C\u00f4ng ty s\u1ebd ti\u1ebfp t\u1ee5c nghi\u00ean c\u1ee9u kh\u1ea3 thi d\u1ef1 \u00e1n x\u00e2y d\u1ef1ng nh\u00e0 m\u00e1y thu\u1ed1c ung th\u01b0 d\u1ef1 ki\u1ebfn s\u1ebd kh\u1edfi c\u00f4ng \u0111\u1ea7u n\u0103m 2019.<\/p>\n

In recent years, DCL\u2019s business results have been much positive, with continuously strong growth in profitability over the years. In 2018, the business plan of Cuu Long Pharmaceutical was set up with net sales of VND 963 billion, equivalent to an increase of 26%; profit after tax is VND 86 billion, equivalent to an increase of 15% compared to 2017. With specific plans and targets, in 2018, DCL will invest more strongly in production and business activities based on the foundation of optimizing the production capacity, multiplying the bio-equivalence test, studying new products to in line with the market trend, perfecting the sale system, standardizing the human resource capacity, professionally managing the Governance and ensuring a strong financial situation. The company will continue to examine the feasibility of constructing a cancer drug factory scheduled to start in early 2019.<\/p>\n

Currently, DCL also owns the largest plant to manufacture empty in the country, occupying 40% market share. DCL Capsule III factory has also just completed construction. DCL will continue to invest in the Capsule 4 factory based on market demand.<\/p>\n

Since the strong investment of parent company FIT with the deeply strategic orientation, Cuu Long Pharmaceutical Joint Stock Company has made great progress to become one of the top prestigious pharmaceutical companies in Vietnam. With this decision, shareholders of the parent company (F.I.T) will be the beneficiaries from the growth of DCL.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

According to the announcement of the F.I.T Group (FIT), the company has completed acquiring of 2 additional million shares of Cuu Long Pharmaceutical JSC. With 2 million additional shares, F.I.T currently holds 74.61% of DCL\u2019s shares, equivalent to 42,402,616 stakes. Transaction time were from 01\/06\/2013 to 08\/06\/2018.u\u1ea3 kinh doanh c\u1ee7a DCL r\u1ea5t kh\u1ea3 quan, khi […]<\/p>\n","protected":false},"author":1,"featured_media":11656,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"rank_math_lock_modified_date":false,"inline_featured_image":false,"footnotes":""},"categories":[93],"tags":[],"class_list":["post-11655","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-from-f-i-t"],"acf":[],"_links":{"self":[{"href":"https:\/\/dcl.com.vn\/en\/wp-json\/wp\/v2\/posts\/11655"}],"collection":[{"href":"https:\/\/dcl.com.vn\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dcl.com.vn\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dcl.com.vn\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/dcl.com.vn\/en\/wp-json\/wp\/v2\/comments?post=11655"}],"version-history":[{"count":0,"href":"https:\/\/dcl.com.vn\/en\/wp-json\/wp\/v2\/posts\/11655\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dcl.com.vn\/en\/wp-json\/wp\/v2\/media\/11656"}],"wp:attachment":[{"href":"https:\/\/dcl.com.vn\/en\/wp-json\/wp\/v2\/media?parent=11655"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dcl.com.vn\/en\/wp-json\/wp\/v2\/categories?post=11655"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dcl.com.vn\/en\/wp-json\/wp\/v2\/tags?post=11655"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}